The trading price of Microbot Medical Inc (NASDAQ:MBOT) closed lower on Monday, February 10, and closing at $2.31, -9.41% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $2.01 and $2.315. In examining the 52-week price action we see that the stock hit a 52-week high of $3.38 and a 52-week low of $0.82. Over the past month, the stock has gained 23.53% in value.
Microbot Medical Inc, whose market valuation is $66.17 million at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.18 per share this quarter, however they have predicted annual earnings per share of -0.71 for current year and -0.52 for next year.
On the technical side, indicators suggest MBOT has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned MBOT a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Microbot Medical Inc (MBOT) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that MBOT’s price is currently 19.57% off the SMA20 and 52.79% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.25, and weekly volatility stands at 15.13%. When measured over the past 30 days, the indicator reaches 15.48%. Microbot Medical Inc (NASDAQ:MBOT)’s beta value is currently sitting at 1.53, while the Average True Range indicator is currently displaying 0.31.
To see how Microbot Medical Inc stock has been performing in comparison to its peers in the industry, here are the numbers: MBOT stock’s performance was -9.41% in the latest trading, and 89.34% in the past year.
An evaluation of the daily trading volume of Microbot Medical Inc (NASDAQ:MBOT) indicates that the 3-month average is 3.18 million. However, this figure has increased over the past 10 days to an average of 2.92.
Currently, records show that 28.64 million of the company’s shares remain outstanding. The insiders hold 18.02% of outstanding shares, whereas institutions hold 8.21%. The stats also highlight that short interest as of 2024-10-31, stood at 0.57 million shares, resulting in a short ratio of 2.65 at that time. From this, we can conclude that short interest is 351.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 0.32 million. However, since the stock’s price has seen 106.25% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
